- Conditions
- COVID-19, Atrial Fibrillation New Onset
- Interventions
- ILR, PMK, ICD
- Device
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 2
- States / cities
- Kansas City, Kansas • Austin, Texas
Source: ClinicalTrials.gov public record
Updated Nov 22, 2021 · Synced May 22, 2026, 1:07 AM EDT